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Myocardial contrast echocardiography has been shown
recently to accurately assess the "area at risk" for ne-
crosis after acute coronary occlusionin the experimental
model. Risk area quantitation, however, has been stud-
ied primarily from single tomographic planes. Because
the three-dimensional extent of myocardial necrosis de-
pends on the total volume of myocardium at risk, the
total left ventricular "area at risk" was determined in
11 dogs (Group A) with either left anterior descending
or left circumflex artery occlusion using contrast echo-
cardiography and compared with risk area determined
by technetium autoradiography. An excellent correla-
tion was found between the two methods (r = 0.96, y
= 0.9lx + 1.5, P < 0.001, SEE =3.17). A comparison
of risk area for individual levelsof the left ventricle using
both methods, however, showed some variation in the
Recent studies (1- 13) have demonstrated that both intraco-
ronary and intraaortic injection s of echocardiographic con-
trast agents can enhance the echo intensity of the normally
perfused myocardium. In the canine model, this technique
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degree of correlation, with the poorest fit beingapparent
at the apex. To identify the source ofthe variation, errors
caused by data registration were minimized in six ad-
ditional dogs (Group B) by implanting epicardial mark-
ers at a single leveland measuring "area at risk" at this
level using both methods. When no registration error
was present , the correlation between the two methods
was excellent (r = 0.99, y = 0.92x + 2.6, P < 0.001,
SE~ = 0.55).
In conclusion, the " area at risk" for infarction after
acute coronary occlusion can be determined accurately
for the entire left ventricle as well as for a single tomo-
graphic slice using myocardial contrast eehocardlog-
raphy. This was validated using technetium autoradiog-
raphy, which is an established method of determining
"area at risk" in the experimental setting.
has been used to delineate areas of underperfused or isch-
emic myocardium after total coronary artery occlusion (6-13).
A number of contrast agents have proven effective in pro-
ducing myocardial opacification without having a significant
myocardial depressant effect (7-9). These include gelatin-
encapsulated microbubbles (6), carbon dioxide-enriched sa-
line solution (1,7), hydrogen peroxide (4, 8, 10) and an ag-
itated mixture of Renografin-76 and saline solution (9). Al-
though this technique has been proven capable of defining
the perfusion territory of a coronary artery in a single short-
axis plane , its validity in assessing total left ventricular
" area at risk" has not been established. Because the entire
left ventricular "area at risk" from myocardial necrosi s,
rather than the risk area within a single tomographic plane ,
determines the three-dimensional extent of infarction, the
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current study was undertaken to determine the ability of
contrast echocardiography to define the total left ventricular
"area at risk" for necrosis after coronary artery ligation.
The echocardiographic risk area thus defined was compared
with that obtained by technetium autoradiography, an in-
dependent and established method for defining myocardial
perfusion deficit in the experimental laboratory (14,15).
Methods
Animal preparation. Twenty-one mongrel dogs weigh-
ing 26 ± 4 kg (mean ± 1 SD) were anesthetized with 0.30
mg/kg of intravenous sodium pentobarbital, intubated and
ventilated with a Harvard respirator. A median sternotomy
was performed and the heart suspended in a pericardial
cradle. Catheters were placed in the aorta, left ventricle and
left atrium for hemodynamic monitoring and myocardial
perfusion determination. Electrocardiographic leads were
attached in a standard fashion and hemodynamic and electro-
cardiographic monitoring was performed using a multi-
channel recorder (Sanborn 7700, Hewlett-Packard).
The left main coronary artery and the proximal or mid-
portions of the left anterior descending artery and the left
circumflex artery were carefully dissected free from sur-
rounding tissues and ties were placed loosely around them.
An electromagnetic flow probe (no. 2.0, Statham Instru-
ments I was placed snugly around the proximal left anterior
descending artery and baseline coronary flow was recorded
using a flow meter (SP 2202, Statham Instruments). The
right femoral artery was then exposed and an 8F catheter
was introduced into it and positioned in the descending
aorta. This catheter was attached to a silastic tubing with a
.yIn inch internal diameter (Dow Corning), which was con-
nected to a Gregg cannula by a roller pump. This system
was primed with a 0.9% sodium chloride solution and the
Gregg cannula introduced into the ascending aorta through
the len common carotid artery (Fig. 1). The roller pump
was then started at a flow rate of 100 mllmin. The tip of
the Gregg cannula was carefully introduced into the left
main coronary artery and firmly secured there with a silk
tie. The roller pump was adjusted so that the flow measured
in the left anterior descending artery by the flow probe after
cannulation was similar to the baseline flow.
In six dogs (Group B) the midpapillary muscle level was
identified by echocardiography and two 3 mm plastic beads
were sutured on the epicardium 6 em apart at this level.
This was done to identify the midpapillary muscle level
during echocardiographic examinations and subsequent au-
toradiography for a precise correlation of echocardiographic
and radionuclide data.
Experimental protocol. Baseline aortic and left ven-
tricular pressures were recorded and microspheres injected
into the left atrium for estimation of control myocardial
blood flow. Control echocardiographic recordings were ob-
R.FEMORAL
ARTERY
Figure 1. Diagrammatic representation of the animal preparation
used in our study (see text for details). L = left; R = right.
tained before and after injection of contrast material. Of the
15 dogs in Group A, 7 had left anterior descending artery
occlusion and 8 had left circumflex artery occlusion. All
six dogs in Group B underwent left circumflex artery oc-
clusion. Hemodynamic and echocardiographic data were
recorded immediately and 3 hours after coronary occlusion.
At 3 hours after occlusion, radioactive microspheres were
injected into the left atrium to determine myocardial blood
flow. After this, 1 million microspheres labeled with 13
mCi of technetium-99m were injected into the left atrium.
Five minutes later, the dog was sacrificed and the heart
removed from the chest.
Two-dimensional echocardiographic studies. Two-
dimensional echocardiographic studies were performed us-
ing a commercially available mechanical sector scanning
system with a 5 MHz transducer (ATL mark III or Diasonics
CY 100). Images were recorded on a videotape using a V2
inch (1.27 em) YHS recorder (Panasonic NY 8200). In 15
dogs (Group A), multiple tomographic imaging planes were
recorded. These included five short-axis views (mitral valve,
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chordal, high papillary muscle, low papillary muscle and
apical levels) and two orthogonal parasternal equivalent long-
axis views. In the short-axis views, the transducer was man-
ually moved from the base of the heart to the apex so that
the cross sections obtained were parallel to each other and
perpendicular to the long axis of the left ventricle. In the
remaining six dogs (Group B), the transducer was fixed at
the midpapillary muscle level using a clamp affixed to the
procedure table. This level was confirmed during the entire
study by echocardiographic visualization of the previously
sutured plastic beads. The gain settings were optimized at
the beginning of the study and kept constant throughout the
recording period. In all studies, a saline bath acted as an
acoustic interface between the heart and the transducer. This
was achieved by attaching the edges of a polyethylene sheet
to the sternal edges and suspending it to cover the anterior
surface of the heart; this plastic trough was filled with 0.9%
sodium chloride solution.
Contrast agent. An agitated mixture of equal amounts
of saline solution and Renografin-76 (diatrizoate meglu-
mine and diatrizoate sodium, 18.5 g/50 ml, ER Squibb) was
used as a flow marker on the basis of its ability to enhance
echo intensity as described by Tei et al. (9). Two ml of this
mixture was injected into the left main coronary artery using
the Gregg cannula. The Gregg cannula was used because it
allowed adequate mixing of the contrast agent and, thus,
prevented streaming. Figure 2A is an example of a control
recording of a short-axis view of the left ventricle at the
chordal level before the injection of contrast material; Figure
2B shows the normal diffuse increase in echoes in the myo-
cardium after the injection of contrast material. The contrast
enhancement is homogeneous throughout the majority of
the tomographic slice. Two small areas with apparent lack
of contrast enhancement, however, can be noted in the lat-
eral aspects of the myocardium at roughly the 7:30 and 4:30
positions. These areas were seen in all the studies and this
phenomenon appears to represent attenuation of the echo
signal as it traverses the thickest segment of left ventricular
myocardium.
Quantification of "areas at risk." The recorded im-
ages were analyzed on a commercially available off-line
computer system (Microsonics, Easy View II). The video
recordings were initially reviewed to select cycles in which
the left ventricle was optimally visualized just before and
after contrast injection at each short axis level. Selected
cycles were transferred to a video disc system (Sony SVM
1010) and the end-diastolic frame of the cycle showing best
delineation of the area with no contrast (risk area) at each
level was selected for analysis. Figure 3A is an example of
a postligation (left circumflex artery) echocardiographic re-
cording after contrast injection into the left main coronary
artery. There is increased echo intensity in the normally
perfused myocardium and absence of contrast in the non-
perfused area.
Figure 2. Two-dimensional echocardiographic short-axis view at
the chordal level before coronary occlusion: A, Before injection
of contrast agent and B, after injection.
To quantitate the area at risk (AR) for each level, the
total area within the epicardium (EPA) was digitized using
a cursor controlled with a joy stick. After this, the area of
the left ventricular cavity defined by the endocardium (ENA)
was digitized. Myocardial area (MA) was then expressed
as EPA - ENA. Next, AR was digitized for each level.
This was assumed to be the area showing no myocardial
enhancement (Fig. 3A) and was expressed in both absolute
terms (cnr') and relative terms (percent of total myocardium)
for each level using the following equation:
AR (cm/)
% AR for single level = 2 x 100.
MA (em)
To calculate the total left ventricular risk area (tAR),
the area at risk for all five levels was added. This was divided
by the sum of the myocardial area at all the levels (tMA).
The percent of total left ventricle (LV) at risk was then
calculated using the following equation:
tAR (crrr')
% AR for total LV = 2 x 100.
tMA (em)
We chose to calculate the total left ventricular risk area in
this manner instead of averaging the risk area for all
lACC V, I 4. No.6
Decembe'1984:1272-82
KA UL ET AL.
CONTRAST ECiIOCARDlOGRAPHY IN MYOCARDIAL ISCHEMIA
1275
Figure 3. A. Two-dimensional contrast echocar-
diographic short-axis view at the chordal level
showing an "area at risk" in the posterior wall of
the left ventricle after left circumflex coronary ar-
tery occlusion . B. Technetium autoradiograph
showing a risk area (cold spot) at the same level of
the left ventricle corresponding to the echocardio-
graphic short axis view in A. C, Method by which
regional myocardial blood flow was measured using
radiolabeled microspheres.
A Contrast Echocardiography B Technetium Autoradiography
C Microspheres
five planes because we wanted to weight the larger myo-
cardial areas appropriately toward the base of the heart com-
pared with the apex.
Technetium autoradiography. Three hours after coro-
nary occlusion, approximately I million microspheres la-
beled with 13 mCi of technetium pyrophosphate were in-
jected into the left atrium . The heart was allowed to beat
for 5 minutes after this injection and the animal was then
sacrificed . After sacrifice, the heart was removed from the
chest and the atria, great vessels and right ventricular free
wall were cut away, leaving the appendages of the anterior
and posterior right ventricular walls for purposes of align-
ment. In the Group A dogs, with a finger placed between
the papillary muscles within the left ventricular cavity as a
guide, a I mm deep longitudinal incision was made on the
epicardial surface of the left ventricle parallel to the ven-
tricular long axis and passing between the two papillary
muscles. This incision, the appendages of the right ven-
tricular walls and the internal landmarks such as papillary
muscles were used for subsequent alignment of slices for
purposes of analysis. The heart was cut into multiple slices
(usually seven) I em thick starting from the mitral valve
level and proceeding to the apex. In the Group B dogs with
epicardial plastic markers, the heart was sliced on either
side of the beads perpendicular to the long axis of the left
ventricle. The slice thus obtained was I em thick. For pur-
poses of analysis , the beads and the papillary muscles were
used as landmarks for the alignment of the slices in this
group of dogs .
After a clear plastic sheet was placed over the slices.
the endocardial and epicardial contours were drawn man-
ually . An X-ray film (Kodak XRP-I) was placed on the
slices and this was allowed to stand for 4 to 6 hours at room
temperature in an X-ray film casette. The films were then
developed using an automatic processor (Kodak RP Xomat,
model MGA-N) to obtain high quality autoradiographs
(14 ,15) . The perfused area appeared as a hot (black) spot
whereas the area at risk appeared as a cold spot (Fig. 3B).
The autoradiographs were then superimposed over the plas-
tic sheet on which the epicardial and endocardial borders
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had been drawn previously to define the endocardial and
epicardial edges. Using a commercially available computer,
the entire myocardial area and area at risk were digitized
using a digitizing pad equipped with a cursor. Area at risk
was expressed in absolute values as ern? and in relative
values as percent of myocardium at risk. Percent of myo-
cardium at risk at each level and percent of entire left ven-
tricle at risk were then calculated using the same equation
as used for echocardiography (see foregoing).
Myocardial perfusion measurements. Baseline myo-
cardial blood flow was estimated by injecting approximately
4.5 million scandium-do-labeled microspheres (New Eng-
land Nuclear) into the left atrium. These microspheres were
14 to 16 Il. in size and had been agitated in a 10 ml saline
solution before injection. The total activity was 30 mCi.
Starting with the injection of the spheres, collection of ref-
erence blood samples was initiated from the arterial line
using a Harvard pump. These were collected into three vials
during 2 minutes (40 second collection for each vial). At 3
hours after occlusion, stannous-113-labeled microspheres
were injected into the left atrium. The number of spheres
and the dose of radioactivity were similar to that of scan-
dium-46-labeled spheres.
Myocardial blood flow determinations were made 48hours
after the experiment (16). This was done differently for
Group A and Group B dogs. In Group A dogs (multiple
ventricular slices), each slice was cut into either five or six
wedge-shaped segments depending on the size of the slice.
In Group B dogs, the single slice under investigation was
cut into 16 wedges to improve the resolution of the method
(Fig. 3C). Each slice and segment was weighed. These
myocardial samples and reference blood samples were counted
in a well counter (Auto-Gamma scintillation spectometer,
Packard) for 5 minutes to collect at least 10,000 counts for
each isotope. The scandium-46 was counted within an 800
to 1,200 KeV window and the stannous-I 13 within a 350
to 435 KeV window. A computer program was used to
correct for activity spilling from one window to another.
Regional myocardial blood flow was calculated using a com-
puter algorithm. Baseline and postocclusion blood flow val-
ues were expressed as ml/min per g of tissue and as the
ratio of flow in the ischemic zone to flow in the normal
blood zone. Postocclusion regional blood flow was consid-
ered abnormal if it was less than 20% of control flow (16).
Data analysis. All data are expressed as mean values
± standard deviation. Linear regression analysis (BMDPIR:
Department of Biomathematics, University of California at
Los Angeles, California, revised 1983) was performed to
determine correlation coefficients among the following: I)
area at risk in individual slices measured by autoradiography
and echocardiography, 2) total left ventricular area at risk
measured by both methods, and 3) area at risk measured
by contrast echocardiography, technetium autoradiography
and radioactive microspheres in Group B dogs. The differ-
ence in mean values was considered significant at p < 0.01.
The difference in the correlation coefficients among the
different tomographic levels in Group A dogs was consid-
ered significant at p < 0.01 using a Fisher's Z transform.
To establish interobserver variability for risk area mea-
surement by contrast echocardiography and technetium au-
toradiography, two sets of independent blinded observers
measured areas at risk obtained by both methods in six dogs.
Thus observers who measured the area at risk by autora-
diography were different from those who measured area at
risk by contrast echocardiography. A single observer in each
set then repeated the measurements several days later to
establish intraobserver variability. Inter-and intraobserver
errors were expressed as the square root of the variance
using an analysis of variance model (BMDP8V). Similarly,
to determine the reproducibility of myocardial contrast echo-
cardiography for the estimation of area at risk, repeated
injections of contrast agent were made in five Group B dogs
and risk area was measured after each injection. The cor-
relation between these risk area measurements was then
determined using a regression model (BMDPIR) and error
of the method was expressed as the square root of the var-
iance (BMPD2V).
Results
For the purpose of analysis, the dogs were divided into
two groups: Group A, which consisted of 15 dogs in which
risk area was determined at multiple levels and total left
ventricular risk area was calculated, and Group B, which
consisted of 6 dogs in which data were collected for a single
slice.
Group A (Data for Multiple Ventricular Levels)
In this group, complete data were available for analysis
in 12 of the 15 dogs (6 with left anterior descending artery
occlusion and 6 with left circumflex artery occlusion; the
remaining 3 died at different intervals after coronary occlu-
sion and complete data could not be obtained. In an addi-
tional dog that completed the experimental protocol, risk
area was confined to the apical cap of the left ventricle.
Although this could be readily visualized on the long-axis
views, we could not define it on the apical short-axis views.
We were thus unable to compare contrast echocardiographic
data with autoradiographic data in this dog and, therefore,
we are presenting data on 11 dogs in this group.
Area at risk by contrast echocardiography. In these
11 animals, 55 short-axis echocardiographic images (five
levels for each dog) and 16 long-axis images (single standard
long-axis images in 6 dogs and two orthogonal long-axis
images in 5 dogs) were analyzed for area at risk. The results
of the short-axis views are presented in Table I. The area
at risk for a single level varied from 0 to 80% by this method.
The area at risk for the entire left ventricle as estimated by
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Table 1. Measurements of Area at Risk (%) in 11 Group A Dogs
Dog No. Apex LPM HPM Chord MY TLY
A. Contrast Echocardiography
I 0.0 37.5 44.9 46.2 54.4 39.5
2 0.0 24.6 45.3 32.4 29.9 29.2
3 44.3 48.9 48.9 15.4 20.8 33.5
4 0.0 22.1 21.4 19.4 20.3 17.9
5 11.4 17.4 11.5 18.9 15.3 14.3
6 0.0 25.2 0.0 0.0 0.0 4.9
7 69.1 80.0 33.6 0.0 0.0 31.8
8 76.0 51.8 19.6 0.0 0.0 22.0
9 27.3 28.7 0.0 0.0 0.0 9.6
10 54.7 34.0 0.0 0.0 0.0 21.6
II 61.0 31.4 0.0 0.0 0.0 14.6
B. Technetium Autoradiography
I 0.0 34.8 37.0 44.5 57.8 36.5
2 29.8 34.5 31.0 30.2 29.8 29.4
:3 53.2 31.5 31.0 14.2 19.4 30.7
4 0.0 12.7 18.9 18.0 22.7 16.0
5 28.9 18.1 10.8 10.3 10.2 16.1
6 0.0 9.8 0.0 0.0 0.0 3.9
7 54.7 69.9 30.0 0.0 0.0 31.3
8 47.7 27.7 21.5 0.0 0.0 27.8
9 36.1 14.7 0.0 0.0 0.0 13.3
10 43.8 25.8 0.0 0.0 0.0 18.3
II 49.2 15.6 0.0 0.0 0.0 11.6
Chord chordal level; HPM = high papillary muscle level; LPM low papillary muscle level;
MY = mitral valve level; TLY = total left ventricular area at risk.
this technique varied from 4.9 to 39.5%. The mean areas
at risk for each level are presented in Table 2.
Area at risk by technetium autoradiography. Seventy
autoradiographic images were obtained from the 11 animals
(five to eight levels for each dog). All images in a given
dog were analyzed to calculate the total left ventricular area
at risk for that animal. Fifty-five of these 70 images were
analyzed for area at risk at individual levels for comparison
with corresponding echocardiographic short-axis levels. These
corresponding levels were determined by the plane at which
the slices were made and by the internal landmarks (Table
1). The area at risk for the entire left ventricle varied from
3.9 to 36.5%. Table 2 shows the mean area at risk for each
level. The area at risk for a single level corresponding to
the echocardiographic short-axis level varied from 0 to 69.9%.
Area at risk by radioactive microspheres. Because
cutting each slice into only five or six segments did not
produce adequate resolution, we did not routinely measure
risk area in this group of dogs by this method. However,
in dogs in which there was extreme discordance between
risk area measured by autoradiography and echocardiog-
raphy (Dogs 2, 5 and 8), the area at risk at the apex defined
by the microsphere technique was analyzed. In these three
segments, the risk area was 33, 33 and 40% by micro-
spheres, 29.8, 28.9 and 47.7 by autoradiography and 0,
11.4 and 76% by contrast echocardiography, respectively.
Table 2. Comparison of Area at Risk (%) Using Technetium Autoradiography and Contrast Echocardiography in 11 Group A Dogs
(mean ± 1 SO)
Technetium Contrast Correlation
Location Autoradiography Echocardiography Coefficients SEE
Apex 31.2 ± 21.8 31.3 ± 30.6 r = 0.67, P < 0.001 16.4
LPM 26.8 ± 16.9 36.5 ± 17.9 r = 0.85, P < 0.001 9.86
HPM 16.4 ± 14.7 20.5 ± 19.9 r = 0.96, p < 0.001 4.91
Chord 10.7 ± 15.1 12.0 ± 16.0 r = 0.99, P < 0.001 2.56
MY 12.7 ± 18.6 12.8 ± 17.7 r = 0.99, P < 0.001 3.0
TLY 21.4 ± 10.5 21.7 ± 10.8 r = 0.96, P < 0.001 3.17
--_.
Abbreviations as in Table I.
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Figure 4. Relation between the "area at
risk" by contrast echocardiography and
technetium autoradiography for the five
short-axis levels in the II dogs in Group
A. All correlations are significant (p <
a.DOI ). The correlations are good at all
levels except the apex where contrast
echocardiography underestimates the risk
area. HPM == high papillarymuscle; LPM
== low papillary muscle; MY == mitral
valve.
CONTRAST ECHOCARDIOGRAPHY (%)
•
AR by TA = .91 AR by CE + 1.5
(r =96, p< .OOI, n=11l
ln these dog s. the rriicrosphere data supported the accuracy
of the autoradiographic data . More over , in the one dog not
included in the anal ysis that showed a small risk area at the
ape x by autoradiography and no risk area by contrast echo-
cardiography, the microspheres also demonstrated a small
apica l risk area.
Comparison of areas at risk obtained by contrast
echocardiography and technetium autoradiography.
For individual levels. In Group A dogs , there was no sig-
nificant d ifference in the mean risk areas obtained at the
five levels by the two methods (Table 2). The correlation
between the risk areas by the two methods was also excellent
at all level s except the apex (Table 2, Fig . 4). The weaker
correlation at the apex with an r value significantly different
(p < 0 .0 I) from other levels was becau se in one animal
(Dog 2) the short-axis views obt ained by contrast echo-
cardiography failed to demarcate a risk area at the apex
wh ile risk area at other levels was clearly seen (T able I).
Alth ough the risk area at the apical leve l in this do g could
not be visua lized in the short-axis view, it was clearly de-
fined in the long-axi s view . Sim ilarl y, in the one dog not
included in this anal ysis in which a small risk area was
con fined onl y to the apex , it could be appreciated onl y in
the long-axis views .
For the entire left ventricle. There was no significant
difference in the area at risk co mputed for the entire left
ventricle by either method (Table 2) . The correlation be-
tween the two methods was good (r = 0 .96) . According to
the regre ssion equation, area at risk by technetium autora -
d iography = 1.5 + 0 .91 x area at risk by contrast echo-
cardiography (p < 0.001) (Fig. 5). Th e slope of the cor-
relation was not significantly di fferent from unity. Thus, in
spite of a poor correlation at the ap ical level , the correlation
for the entire left ventricle was excellent. Thi s is because
the apical region is sma ll co mpared with the rest of the left
ventricle, so that even a moderate- sized area at risk in this
region would not make a significant difference in the com-
putation of the total left ventricular risk area . Thi s is sub-
Figure 5. Relation between the total left ventricular "area at risk"
by contrast echocardiography and technetium autoradiography in
the II dogs in Group A. The thin line represents the line of
identity. An excellent correlation (bold line) is apparent between
the two techniques. AR = area at risk; CE = contrast echocardi-
ography; TA = technetium autoradiography.
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Table 3. Area at Risk by Contrast Echocardiography, Technetium Autoradiography and
Radioactive Microspheres in 6 Group B Dogs
Dog No. AR-CE AR-TA AR-MIC
I 35.4 34.7 37.4
2 25.8 25.6 25.0
3 38.4 38.4 31.0
4 26.2 27.0 37.5
5 30.7 30.9 12.5
6 19.5 20.9 12.5
Mean 29.9 29.6 26.0
± SD 6.9 6.4 11.4
Corr coeff 0.99 • 4 0.50 ..
p value < 0.00 1 < 0.0 1
SEE 0.55 6.24
AR-CE = area at risk by contrast echocardiography ; AR-MIC = area at risk by radioactive microspheres;
AR-TA = area at risk by technetium autoradiography; Corr coeff = correlation coefficient; SD = standard
deviation; SEE = standard error of estimate .
stantiated by data on Dog 2 (Table I) in which contrast
echocardiography failed to demonstrate a risk area in the
apex whereas technetium autoradiography demonstrated a
29.8%: risk area . The total left ventricular risk area by both
methods, however, was 29.2 versus 29.4% for contrast
echocardiography and technetium autoradiography,
respecti vely.
Group B (Data for a Single Ventricular Level)
Because the alignment for each level between echocar-
diographic planes and autoradiography in Group A dogs
was done utilizing internal landmarks, it was impossible to
be certain that the two levels corresponded exactly. There-
fore. six additional animals (Group B) were included in the
study in which epicardial markers were placed, so that the
comparison between the echocardiographic planes and au-
toradiographs could be established precisely. Complete data
were available in all the six dogs in this group.
Six short-axis images (midpapillary muscle LeveLforeach
dog) were anaLyzed for area at risk (TabLe 3). The area at
risk by this method varied from 19.5 to 38.4% (mean 29.3
± 6.9). The corresponding autoradiographic area at risk
varied from 20.9 to 38.4% (mean 29.6 ± 6.4). The cor-
relation between contrast echocardiography and technetium
autoradiography was excellent (r = 0.99) . According to the
regression equation, area at risk by technetium autoradiog-
raphy = 2.6 ± 0.92 x area at risk by contrast echocardi-
ography (p < 0.001) (Fig . 6). The mean risk area in the
six dogs as measured by radioactive microspheres was 26.1
± 11.4%. Although this was not significantly different from
Figure 6. Relation between the "area at
risk" by contrast echocardiography and
technetium autoradiography in the six dogs
in Group B in which the transducer was
fixed at a single short-axis level (midpap-
iIIary) during echocardiography and in
which the heart was cut at the same level
for autoradiography . The thin line rep-
resents the line of identity . An excellent
correlation (bold line) is apparent be-
tween the two techniques . Abbreviations
as in Figure 5.
AR by TA = .92 AR by CE + 2.6
(,= .99, p< .001l
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the mean risk area determined by technetium autoradiog-
raphy or contrast echocardiography , the correlation for in-
dividual sections with both these techniques was poor. The
poor correlation was noted despite the fact that 16 myo-
cardial segments were analyzed for each slice.
Observer variability and reproducibility. Inter- and
intraobserver correlation and error for both contrast echo-
cardiography and technetium autoradiography were good
(Table 4).
The reproducibility of myocardial contrast echocardi-
ography for measurement of risk area between two injec-
tions of contrast agent was also good (r = 0.98, y = O.92x
+ 1.1, P < 0.001, SEE = 1.1) with a small intrainjection
error of 1.5%.
Discussion
Determination of total left ventricular risk area. The
present study demonstrates that the total left ventricular
"area at risk" for infarction after acute coronary occlusion
can be determined in vivo using contrast two-dimensional
echocardiography and that this measurement compares fa-
vorably with the established in vitro technetium autoradio-
graphic method of assessing risk area. A further good cor-
relation was noted between echocardiographic and
autoradiographic data within individual ventricular sections
with the exception of the cardiac apex. Because the apex
constitutes only a small part of the total left ventricular
myocardium, less precise echocardiographic measurement
of risk area at this level did not significantly alter the de-
termination of total left ventricular risk area using the con-
trast echocardiographic method.
The myocardial area, or more appropriately, volume at
risk of infarction after coronary occlusion, is a critically
important determinant of the extent and magnitude of sub-
sequent myocardial necrosis (17). Because this "area at
risk" may vary greatly between individuals despite coronary
ligation or occlusion at apparently comparable levels of the
same vessel, analysis of changes in infarct size or regional
function is only meaningful if considered in relation to the
initial risk area (17,18). Furthermore, because the "area at
risk" has a three-dimensional representation, the accurate
assessment of the total geographic expression of the risk
area is more important than that at a selected level within
the ventricle (19).
There are several postmortem methods ofestimating risk
area in the experimental laboratory. These include post-
mortem coronary angiography (20), coronary stereoangiog-
raphy (19), injection of colored dyes into the coronary cir-
culation (5,8) and technetium autoradiography (14,15) .
Although postmortem coronary angiography can localize
and quantitate coronary occlusion . it does not provide direct
information on the perfusion territory of a coronary artery.
Coronary stereoangiography , on the other hand, does pro-
vide information on the area of perfusion of a coronary artery
in tomographic slices (19). However, the method is ex-
tremely tedious and is not universally available. The injec-
tion of colored dyes like monastral blue similarly provides
information on the postmortem risk area in single or multiple
tomographic slices. Like coronary stereoangiography, how-
ever, the risk area measured by this technique depends on
the physical properties and rate of injection of the contrast
agent (19) . Although technetium macroautoradiography is
a relatively simple and well established method of risk area
determination, like all in vitro methods, it can be used to
determine the risk area at only one point in time and cannot
be used serially to determine the effects of interventions on
the risk area or the mechanical changes that may have oc-
cured within the risk area secondary to myocardial necrosis.
Furthermore. because it is a postmortem method it cannot
be a reference from which to assess subsequent events.
Until recently, there was no reliable method of delin-
eating the' 'area at risk" in a beating heart. Several reports
(1-13), however, have suggested that contrast echocardi-
ography can be used to define the perfusion territory of a
coronary artery. Although these studies have yielded useful
information, attempts have been confined mostly to defining
the perfusion territory of a selected coronary vessel in a
single tomographic plane (1-7,9-13) . Because the area of
myocardium involved after occlusion of a coronary artery
has a three-dimensional rather than a planar representation,
it would be more desirable to measure the total left ven-
tricular risk area (19) . The present study demonstrates that
contrast echocardiography can accurately determine the three-
dimensional extent of the risk area in a beating heart. Our
results further suggest that this method is associated with
Table 4. Inter- and Intraobserver Variability in Studies in 6 Dogs
Contrast Echocardiography Technetium Autoradiography
Interobserver error
Interobserver corr
Intraobserver error
Intraobserver corr
1.06%
r = 0.97 (p < 0.001)
Y = 0.96x + 1.63
0.20%
r = 0.99 (p < 0.001)
Y = 1.0x - 0.04
1.94%
r = 0.90 (p < 0.003)
Y = 0.90x - 0.57
1.55%
r = 0.87 (p < 0.(01)
Y = 0.86x + 3.45
corr = correlation (using linear regression analysis) .
lACC \d. 4. NO.6
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an acceptable intra- and interobserver variability. These fac-
tors, coupled with the ability to use this technique serially,
make 11 an ideal method to assess the risk area after coronary
occlusion and to study the effects of interventions on this
area.
Determination of risk area in a single tomographic
plane. Although our data also support previous observa-
tions that contrast echocardiography provides accurate mea-
surement of risk area in single tomographic planes (6-10),
our correlation was not as good for some levels as others.
This variation at individual levels could be caused by either
intrinsic limitations of the techniques used or a lack of
precise data registration. Because we aligned echocardio-
graphic and autoradiographic data using anatomic land-
marks. such as the papillary muscles and right ventricular
free wall appendages, there was no way of being certain
that no error occurred in data registration. Therefore, we
performed experiments on six additional dogs (Group B) in
which epicardial markers were placed that could be recorded
throughout the echocardiographic study. The transducer was
fixed at the level of these markers throughout the experiment
and the heart sliced at the same level. This ensured minimal
registration error, and using this method we found nearly a
one to one correlation between contrast echocardiography
and technetium autoradiography.
Comparison with previous studies. The slight differ-
ences between our data and those previously published ap-
pear til be related to the accuracy of the method used to
measure postmortem risk area. Armstrong et al. (10) for
example, used radioactive microspheres for the determi-
nation of risk area. Although this technique is highly ac-
curate for determining blood flow in any given myocardial
sample and can differentiate between differences in endo-
cardia l and epicardial flow, it is not necessarily an accurate
method of assessing risk area. This results from the need
to section the myocardium for perfusion measurements into
relatively large pieces to obtain a minimal number of counts
that will ensure statistical accuracy (16). Thus, the reso-
lution of the method must be limited by the number of
segments into which the heart is cut. This limitation is
confirmed by the results in our Group B animals in which
the area at risk defined by the microsphere method correlated
poorly with both technetium autoradiography and contrast
echocardiography in spite of the fact that the former is based
on the same principles as the microsphere method. In the
studies by Sakamaki et al. (5) and Kemper et al. (8), colored
dye was injected postmortem into the coronary circulation
to delineate the perfusion territory of the coronary artery.
Although theoretically more precise than the radioactive
microsphere determination of risk area, the delineation of
risk area by this method depends on the viscosity of dye
used, the force of injection and the postmortem patency of
the coronary arteries (19).
Inaccuracy of risk area determination at apex. In our
study, the risk area determination at the apical level was
not as accurate as that at the other levels. This may be
caused by several factors. It is possible that in spite of
holding the transducer perpendicular to the long axis of the
heart, the exaggerated apical motion in a beating heart does
not allow a correct representation of the short axis at this
level. Alternatively, the apical short-axis view, which by
definition includes the left ventricular cavity, may fail to
represent the apical tip of the left ventricle. This explanation
is supported by the fact that although risk area at the apical
level could sometimes not be delineated in the short-axis
view, it was always clearly appreciated in the long-axis
views. Therefore, a method that could incorporate risk area
measurements from different views would correct for errors
caused by the limitations of the apical short-axis view. One
such computer algorithm incorporating different views has
been developed in our laboratory (21).
Technical drawbacks. There are some technical draw-
backs related to the injection of contrast into the coronary
circulation. Injection of tnore than 2 to 3 ml of the agitated
contrast mixture into the left main coronary artery causes a
"blooming effect" with deterioration of the image quality.
Artifacts may also occur within the contrast-enhanced por-
tion of the image. As illustrated in Figure IB, there is
attenuation of the contrast effect where the echo signal has
to traverse a longer segment of the myocardium. This artifact
could conceivably be a source of error in risk area
determination.
Potential clinical use. Although the use of myocardial
contrast echocardiography to assess risk area has yet to be
established in the clinical setting, its potential uses are many.
It has an advantage over coronary angiography because it
can determine precisely the perfusion territory of a particular
stenotic vessel. It has a better resolution than planar thallium
imaging in the determination of risk area and, unlike the
latter, can be used serially to study the effects of interven-
tions such as thrombolysis and angioplasty on coronary ste-
nosis and the effect of drugs on coronary spasm. Although
in our experiment we totally occluded the coronary artery,
there is evidence to suggest that this method can also be
used to define area at risk in the setting of subtotal coronary
occlusion and that the washout rate of contrast from the
ischemic zone can differentiate between degrees of subtotal
occlusion (13). We are presently involved in studying the
effects of contrast agents on myocardial mechanics and his-
tology as well as their effects on the central nervous system
and kidneys. Once it is proven safe, this method could be
used clinically as an adjunct to coronary angiography.
Research efforts are currently directed at developing suit-
able contrast agents that can traverse the pulmonary cir-
culation and cause myocardial contrast enchancement after
injection of contrast material into a peripheral vein. If this
becomes feasible, there may be no need to perform left-
sided catheterization to define area at risk.
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In summary, our results have demonstrated that myo-
cardial contrast echocardiography can accurately determine
the "area at risk" for the entire left ventricle as well as for
a single tomographic plane. Because of its excellent spatial
resolution, small observer variability and potential for serial
use in a beating heart, this method may be superior to the
current methods of assessing risk area in the experimental
laboratory.
We thank Luis Guerrero for technical assistance, Kathleen Lundgren for
expert secretarial assistance, John B. Newell, BA for assistance in statis-
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